Gudgesic AA Tablet is a combination analgesic formulation containing Aceclofenac (100 mg), Paracetamol (325 mg), and Serratiopeptidase (15 mg), designed to provide effective relief from pain and inflammation. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts its effect by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis responsible for pain and inflammation. Paracetamol acts as an analgesic and antipyretic, providing symptomatic relief from mild to moderate pain and fever through central inhibition of prostaglandin synthesis. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of edema and tissue inflammation, enhancing the overall anti-inflammatory effect. This combination is particularly beneficial in managing musculoskeletal disorders, postoperative pain, dental pain, and inflammatory conditions such as arthritis. Gudgesic AA Tablet should be used under medical supervision, with caution advised in patients with gastrointestinal ulcers, hepatic or renal impairment, and hypersensitivity to any component. The synergistic action of these agents provides rapid and sustained relief from pain and inflammation, improving patient comfort and mobility. It is recommended to adhere to prescribed dosages to minimize potential adverse effects and interactions with other medications.